General Cancer Research (including metastasis and immunotherapy)


​Listed below are some of the research projects that ICRF has supported in order to help eradicate General Cancers:

David Gurwitz, Ph.D.
Tel Aviv University
"SSRI antidepressants as anti-cancer therapy: role for down-regulation of miR-221"
Topic:  Using Antidepressants to reduce MicroRNA expression and potentially halt metastasis and chemotherapy resistance


Martin Kupiec, Ph.D.
Tel-Aviv University
"Telomere Length Control and Genome Stability"
Topic:  DNA Damage Response

Sara Eyal, Ph.D.
Hebrew University of Jerusalem
"Non-Invasive In Vivo Optical Imaging of Cancer Multidrug Resistance"
Topic:  Imaging to Predict Response to Chemotherapy


Zvi Granot, Ph.D.
Hebrew University of Jerusalem
"The Effect of VEGF on Neutrophil Function in the Context of Tumor Growth and Metastatic Progression"
Topic:   Immune System Cells and the Tumor Microenvironment, Angiogenesis and Metastasis


Niv Pencovich, M.D., Ph.D.
Tel Aviv Sourasky Medical Center
"Genome-wide characterization of the escape from tumor dormancy"
Topic:  Understanding the molecular mechanisms underlying malignant transformation of dormant tumors